| PATENT NUMBER | This data is not available for free |
| PATENT GRANT DATE | November 10, 1998 |
| PATENT TITLE |
Bacterial strains and use thereof in fermentation process for 2-keto-L-gulonic acid production |
| PATENT ABSTRACT | The present invention relates to a process for the production of 2-keto-L-gulonic acid by fermentative conversion of L-sorbose and/or D-sorbitol. The present invention further relates to novel bacterial strains useful in this process |
| PATENT INVENTORS | This data is not available for free |
| PATENT ASSIGNEE | This data is not available for free |
| PATENT FILE DATE | October 24, 1996 |
| PATENT REFERENCES CITED |
Kieslich, K., volume ed., Biotechnology vol. 6A "Biotransformations," Verlag Chemie, Weinheim, Germany: 1934, pp. 436-437. Tsukada, Y. and Perlman, D., "The Fermentation of l-Sorbose by Gluconobacter melanogenus: General Characteristics of the Fermentation," Biotechnology and Bioengineering XIV :799-810 (1972). Yin, G.-L. et al., "Studies on the Production of Vitamin C Precursor 2-Keto-L-Gulonic Acid from L-Sorbose by Fermentation. I. Isolation, Screening and Identification of 2-Keto-L-Gulonic Acid Producing Bacteria," Acta Microbiologica Sinica 20(3):246-251 (1980). Yin, G.-I. et al., "Studies on Production of Vitamin C Precursor 2-Keto-L-Gulonic Acid from L-Sorbose by Fermentation," Acta Microbiologica Sinica 21(2):185-191 (1981). English Translation of AL1. English Translation of AM2. English Translation of AN1. English Translation of AT1. English Translation of AR2. Abstract of AP1, Derwent World Patents Index, WPI Account No.: 77-48308Y/27. Abstract of AN2, Derwent World Patents Index, WPI Account No.: 95-155907/21. Abstract of AP2, Japio. Martin, C.K. and D. Perlman, "Conversion of L-Sorbose to 2-Keto-L-Gulonic Acid By Mixture of Immobilized Cells of Gluconobacter melanogenus IFO 3293 and Pseudomonas Species," Eur. J. Appl. Microbiol. 3:91-95 (1976). Walker, J.M. and E.B. Gingold, Molecular Biology and Biotechnology, The Royal Society of Chemistry, London, pp. 15-20 (1989). |
| PATENT CLAIMS |
What is claimed is: 1. A process for the production of 2-keto-L-gulonic acid, which comprises culturing microorganism strain NRRL B-21627 or a mutant thereof in a medium containing L-sorbose for a time sufficient for said L-sorbose to be converted to 2-keto-L-gulonic acid; and recovering said 2-keto-L-gulonic acid. 2. The process according to claim 1, wherein said mutant of strain NRRL B-21627 is capable of producing at least about 40 g/L of 2-keto-L-gulonic acid from L-sorbose in pure culture. 3. The process according to claim 1, further comprising converting said 2-keto-L-gulonic acid to ascorbic acid or a salt thereof. 4. The process according to claim 1, wherein said culturing is performed at a pH of about 5.0 to 8.0. 5. The process according to claim 1, wherein said culturing is performed at a temperature of about 22.degree. C. to about 35.degree. C. 6. The process according to claim 1, wherein said microorganism is cultured in pure culture. 7. The process according to claim 1, wherein said microorganism is cultured in a mixed culture with at least one additional microorganism strain. 8. The process according to claim 7, wherein said additional microorganism strain is a member of a genus selected from the group consisting of Aureobacterium, Corynebacterium, Bacillus, Brevibacterium, Pseudomonas, Proteus, Enterobacter, Citrobacter, Erwinia, Xanthomonas and Flavobacterium. 9. The process according to claim 8, wherein said additional microorganism strain is Corynebacterium glutamicum. 10. The process according to claim 9, wherein said Corynebacterium glutamicum is strain ATCC 21544. 11. The process according to claim 1, wherein said L-sorbose is generated by fermentative conversion of D-sorbitol. 12. The process according to claim 11, wherein said L-sorbose is generated by fermentative conversion of D-sorbitol using Gluconobacter oxydans. 13. The process according to claim 12, wherein said Gluconobacter oxydans is strain ATCC 621 or strain IFO 3293 or a mutant thereof. 14. The process according to claim 1, wherein said microorganism resists growth inhibition by 2-keto-L-gulonic acid or chemical derivatives or degradation products thereof. 15. The process according to claim 1, wherein said microorganism strain is NRRL B-21630. 16. A process for the production of 2-keto-L-gulonic acid, which comprises culturing microorganism strain NRRL B-21627 or a mutant thereof together in mixed culture with a microorganism strain capable of converting D-sorbitol to L-sorbose in a medium containing D-sorbitol, for a time sufficient for said D-sorbitol to be converted to 2-keto-L-gulonic acid; and recovering said 2-keto-L-gulonic acid. 17. The process according to claim 16, wherein said additional microorganism strain is a member of the genus Gluconobacter or Acetobacter. 18. The process according to claim 17, wherein said additional microorganism strain is either Gluconobacter oxydans ATCC 621 or Gluconobacter oxydans IFO 3293 or mutants thereof. 19. A biologically pure culture of microorganism strain NRRL B-21627 or a mutant thereof. 20. The biologically pure culture according to claim 19, wherein said mutant is strain NRRL B-21630. |
| PATENT DESCRIPTION |
FIELD OF THE INVENTION The present invention relates to a process for the production of 2-keto-L-gulonic acid by fermentative conversion of L-sorbose and/or D-sorbitol. The present invention further relates to novel bacterial strains useful in this process. BACKGROUND OF THE INVENTION 2-Keto-L-gulonic acid ("2-KLG") is a significant intermediate in the preparation of L-ascorbic acid (vitamin C), an essential nutrient. 2-KLG has been synthesized in the past on an industrial scale using the Reichstein method (Helvetica Chimica Acta 17:311 (1934)). This method, however, has a number of disadvantages for commercial application, including the use of large quantities of solvents and the involvement of a number of complex reaction steps. Accordingly, as an alternative to the Reichstein method, a number of processes employing one or more microorganisms have been developed to produce 2-KLG by fermentation. U.S. Pat. No. 2,421,611, for example, discloses a method involving microbial oxidation of D-glucose to 5-keto-D-gluconic acid, followed by chemical or microbial reduction to L-idonic acid and subsequent microbial oxidation to 2-KLG. Japanese Patent Publication Nos. 39-14493, 53-25033, 56-15877 and 59-35290, for example, disclose similar processes involving the microbial oxidation of D-glucose to 2,5-diketo-D-gluconic acid followed by microbial or chemical reduction to 2-KLG. These methods, however, also suffer from a number of disadvantages that reduce their usefulness in commercial production of 2-KLG. For example, the chemical reduction steps in these methods (i.e. the reduction of 5-keto-D-gluconic acid to L-idonic acid and 2,5-diketo-D-gluconic acid to 2-KLG) are accompanied by problems with controlling the stereochemistry of reduction (thus producing D-gluconic acid and 2-keto-D-gluconic acid, respectively, as byproducts) which, in turn, reduces the yield of 2-KLG. Alternatively, when this reduction is performed by one or more microorganisms, excess sugar is required to provide an energy source for the reduction, which also reduces the yield of 2-KLG. In view of these problems, an alternate pathway has been employed for the fermentative production of 2-KLG, which involves only oxidation of L-sorbose to 2-KLG via a sorbosone intermediate. A number of processes have been developed using this pathway that employ a wide range of microorganisms from the genera Gluconobacter, such as Gluconobacter oxydans (U.S. Pat. Nos. 4,935,359; 4,960,695; 5,312,741; and 5,541,108), Pseudogluconobacter, such as Pseudogluconobacter saccharoketogenes (U.S. Pat. No. 4,877,735; European Pat. No. 221 707), Pseudomonas, such as Pseudomonas sorbosoxidans (U.S. Pat. Nos. 4,933,289 and 4,892,823), and mixtures of microorganisms from these and other genera, such as Acetobacter, Bacillus, Serratia, Mycobacterium, and Streptomyces (U.S. Pat. Nos. 3,912,592; 3,907,639; and 3,234,105). These processes, however, suffer from certain disadvantages that limit their usefulness for commercial production of 2-KLG. For example, the processes referenced above that employ G. oxydans also require the presence of an additional "helper" microbial strain, such as Bacillus megaterium, or commercially unattractive quantities of yeast or growth components derived from yeast in order to produce sufficiently high levels of 2-KLG for commercial use. Similarly, the processes that employ Pseudogluconobacter can require medium supplemented with expensive and unusual rare earth salts or the presence of a helper strain, such as B. megaterium, and/or the presence of yeast in order to achieve commercially suitable 2-KLG concentrations and efficient use of sorbose substrate. Other processes that employ Pseudomonas sorbosoxidans also include commercially unattractive quatities of yeast or yeast extract in the medium. Accordingly, there is a need in the art for microorganism strains which efficiently produce 2-KLG, but without many of the problems associated with the state of the art. SUMMARY OF THE INVENTION It is therefore an object of the present invention to provide microorganism strains which efficiently produce 2-KLG. Other objects, features and advantages of the present invention will be set forth in the detailed description of preferred embodiments that follows, and in part will be apparent from the description or may be learned by practice of the invention. These objects and advantages of the invention will be realized and attained by the methods particularly pointed out in the written description and claims hereof. These and other objects are accomplished by the methods of the present invention, which, in a first embodiment, is directed to a process for producing 2-KLG from L-sorbose, which comprises the steps of culturing in a medium a microorganism of strain NRRL B-21627(ADM X6L) or a mutant or variant thereof, either alone or in mixed culture with one or more helper strains, and then recovering the accumulated 2-KLG. Another embodiment of the present invention is directed to a culture of a microorganism of strain NRRL B-21627 or a mutant thereof, such as NRRL B-21630 (ADM 86-96). It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are intended to provide further explanation of the invention as claimed. BRIEF DESCRIPTION OF DRAWINGS FIG. 1 is a depiction of the RiboPrint.RTM. patterns of bacterial strains capable of producing 2-KLG from L-sorbose. RiboPrint.RTM. pattern (A) was obtained from bacterial strain NRRL B-21627(ADM X6L); RiboPrint.RTM. pattern (B) was obtained from Gluconobacter oxydans strain 4025C (a reisolate of the small-colony component strain of the mixed culture deposit DSM 4027, U.S. Pat. No. 4,935,359); RiboPrint.RTM. pattern (C) was obtained from Pseudomonas sorbosoxidans strain IFO 14502; and RiboPrint.RTM. pattern (D) was obtained from Pseudogluconobacter saccharoketogenes strain IFO 14484. DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS OF THE INVENTION In a first embodiment, the present invention is directed to a fermentation process for the production of 2-keto-L-gulonic acid from L-sorbose which comprises contacting a microorganism with L-sorbose for a sufficient time and then isolating the accumulated 2-KLG. Preferably, the inventive fermentation process comprises cultivating a microorganism in a synthetic or natural culture medium containing L-sorbose for a sufficient time and then isolating the accumulated 2-KLG from the culture medium and/or cells of the microorganism. The microorganism strain employed in the inventive process is preferably bacterial strain NRRL B-21627 (ADM X6L) or a mutant or variant thereof, which is capable of producing at least about 40 g/L of 2-KLG from L-sorbose by fermentation in pure culture, i.e., in the absence of one or more additional microorganism strain(s). Strain NRRL B-21627 (ADM X6L) was deposited at the Agricultural Research Service Culture Collection (NRRL), 1815 North University Street, Peoria, Ill. 61604, U.S.A., on Oct. 1, 1996 under the provisions of the Budapest Treaty and assigned accession number NRRL B-21627. The characteristics of strain NRRL B-21627 (ADM X6L) include: (1) Cell Morphology--gram-negative; can be gram variable in older cultures; pleiomorphic; short rods or coccobacilli; cells appear singly and in pairs; can form short chains or filaments; does not form spores; (2) Colony Morphology--punctiform, convex, entire, smooth, butyrous and translucent; beige or light brown coloration in older colonies on some media; (3) Motility: no motility observed in wet mounts prepared from liquid cultures or 2% agar plate cultures; motility observed by stabbing fresh culture into a plate of BUGM.TM. medium (available from Biolog, Inc., Cat.#70001) that has been partially solidified using 0.3% to 0.4% agar; cells manufacture flagella under conditions used to observe motility; (4) Temperature range: no growth observed at 4.degree. C., 37.degree. C. or 41.degree. C., while good growth observed at 25.degree. C., and 30.degree. C.; (5) pH range: no growth observed at pH 4.5; growth observed at pH 6.2; good growth observed at pH 7.2; (6) Physiological characteristics: (a) catalase: positive; (b) oxidase: positive (c) gelatinase: negative; (d) aerobic, no growth under anaerobic conditions; (e) brown pigment formed from fructose; (f) acid is produced from ethanol; (g) dihydroxyacetone is not produced from glycerol; (h) does not form pellicle or ring within 24 hours in standing glucose or mannitol broth culture at pH in range of 4.0-5.0; and (i) sensitive to streptomycin; and (7) Cultural Characteristics: (a) growth in 3% NaCl: positive; (b) peptone-yeast extract-mannitol agar: growth; (c) Marine agar: slow growth; (d) BUGM.TM. and BUGM-G.TM.: growth; and (e) Brain Heart Infusion agar: growth. (8) RiboPrint.RTM. Analysis: RiboPrint.RTM. analysis involves hybridization of radio-labeled anti-sense RNA to the genetic material being studied, followed by detection of the labeled double-stranded hybrid using gel electrophoresis. The patterns obtained by this method are useful for differentiating not only between organisms of different species, but also between different strains of the same species. RiboPrint.RTM. patterns obtained for strain NRRL B-21627 (ADM X6L) and a number of comparative strains known to be capable of producing 2-KLG from L-sorbose are depicted in FIG. 1. In addition to naturally occurring strain NRRL B-21627 (ADM X6L), mutants and variants thereof may also be employed in the inventive process, provided that these mutants and variants are also capable of producing at least 40 g/L of 2-KLG from L-sorbose in monoculture. Illustrative examples of suitable methods for preparing mutants and variants of the inventive microorganism strains include, but are not limited to: mutagenesis by irradiation with ultraviolet light or X-rays, or by treatment with a chemical mutagen such as nitrosoguanidine (N-methyl-N'-nitro-N-nitrosoguanidine), methylmethanesulfonate, nitrogen mustard and the like; gene integration techniques, such as those mediated by insertional elements or transposons or by homologous recombination of transforming linear or circular DNA molecules; and transduction mediated by bacteriophages such as P1. These methods are well known in the art and are described, for example, in J. H. Miller, Experiments in Molecular Genetics, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (1972); J. H. Miller, A Short Course in Bacterial Genetics, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (1992); M. Singer and P. Berg, Genes & Genomes, University Science Books, Mill Valley, Calif. (1991); J. Sambrook, E. F. Fritsch and T. Maniatis, Molecular Cloning: A Laboratory Manual, 2d ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (1989); P. B. Kaufman et al., Handbook of Molecular and Cellular Methods in Biology and Medicine, CRC Press, Boca Raton, Fla. (1995); Methods in Plant Molecular Biology and Biotechnology, B. R. Glick and J. E. Thompson, eds., CRC Press, Boca Raton, Fla. (1993); and P. F. Smith-Keary, Molecular Genetics of Escherichia coli, The Guilford Press, New York, N.Y. (1989). Mutated strains derived from the inventive organism NRRL B-21627 (ADM X6L) using known methods are then preferably selected or screened for improved 2-KLG production potential or for other desirable properties related to their utility in producing 2-KLG from L-sorbose. In a particularly preferred embodiment of the mutagenesis and screening approach to strain improvement, mutagenized cells are selected on the basis of their resistance to growth-inhibitory concentrations of partially derivatized or degraded 2-KLG , such as 2-KLG derivatives generated by autoclaving or other exposure to heat. In an alternative embodiment, the selective agent may be generated by other means of chemical modification of 2-KLG, including, but not limited to: amino-substitution to create 2-amino-L-gulonic acid or 2-amino-L-idonic acid; oxidation at the C.sub.6 position to create 5-keto-glucaric acid; modifications leading to various thiol- or deoxy-derivatives or various unsaturated derivatives of 2-KGL ; or by any other means that will be clear to individuals versed in the art. A particularly preferred mutant (ADM 86-96) of strain NRRL B-21627 (ADM X6L) was deposited at the Agricultural Research Service Culture Collection (NRRL), 1815 North University Street, Peoria, Ill. 61604, U.S.A., on Oct. 15, 1996 under the provisions of the Budapest Treaty and assigned accession number NRRL B-21630. In accordance with the present invention, the inventive microorganism strain or a mutant or variant thereof is contacted with L-sorbose for a sufficient time and then the accumulated 2-KGL is isolated. Preferably, the microorganism strain is cultivated in a natural or synthetic medium containing L-sorbose for a period of time for 2-KGL to be produced and the accumulated 2-KGL is subsequently isolated. Alternatively, a preparation derived from the cells of the microorganism strain may be contacted with L-sorbose for a sufficient time and the accumulated 2-KGL may then be isolated. As used herein, "a preparation derived from the cells" is intended to mean any and all extracts of cells from the culture broths of the inventive strain or a mutant or variant thereof, acetone dried cells, immobilized cells on supports, such as polyacrylamide gel, .kappa.-carrageenan and the like, and similar preparations. An illustrative example of such a procedure involves adding L-sorbose and CaCO.sub.3 in a suitable aqueous buffer, such as 2-(N-methylmorpholino)ethanesulfonic acid (pH 6.5; 0.5M), to an aqueous extract of the microorganism strain in a shaker flask. This reaction preferably proceeds at a pH in the range of 5.0 to 8.0 at a temperature in the range of 20.degree. C. to 40.degree. C. for about 1 to 100 hours. The concentration of L-sorbose should be about 0.1 to 10% w/v, more preferably about 0.3 to 6% (w/v) and the amount of the preparation derived from the cells of strain NRRL B-21627 (ADM X6L) or a mutant or variant thereof, such as NRRL B-21630 (ADM 86-96), should be about 1 to 30 mg/ml. After shaking for a sufficient period of time under temperature and pH conditions empirically determined to maximize 2-KGL yield, the accumulated 2-KGL may be isolated by conventional methods. The medium used herein may be solid or liquid, synthetic (i.e. man-made) or natural, and contains sufficient nutrients for the cultivation of the inventive microorganism strain. Preferably, the medium employed is a liquid medium, more preferably a synthetic liquid medium. In the various embodiments of the process of the present invention, the starting material, L-sorbose, may be present in the medium prior to introduction of the inventive microorganism strain or may be added to the medium after introduction of the strain, either all at once at the beginning or continuously or in installments over the course of cultivation, or may be generated in situ by fermentative conversion of D-sorbitol. The amount of L-sorbose employed may be determined empirically by one skilled in the art, but is at least sufficient for the microorganism strain to produce at least about 40 g/L of 2-KGL. Preferably, L-sorbose comprises from 3 to 30% (w/v) of the culture medium, more preferably from 5 to 20%. In a preferred embodiment of the present invention, the L-sorbose starting material is generated in situ by fermentative conversion of D-sorbitol using a suitable microorganism or mixture of microorganisms. Any microorganism or mixture of microorganisms that can convert D-sorbitol to L-sorbose in the presence of NRRL B-21627 (ADM X6L) or a mutant or variant thereof while not adversely affecting its ability to convert L-sorbose to 2-KGL may be employed. Preferably, the microorganism employed is a strain of Gluconobacter oxydans, more preferably G. oxydans strain ATCC 621 or G. oxydans strain IFO 3293. According to this preferred embodiment of the present invention, the D-sorbitol starting material may be present in the medium prior to introduction of one or more of the microorganisms or may be added to the medium after introduction of one or more of the microorganisms, either all at once at the beginning or continuously or in installments over the course of cultivation. In addition to L-sorbose and/or D-sorbitol, the natural or synthetic culture medium also contains a nitrogen source, suitable inorganic salts, and, as appropriate, various trace nutrients, growth factors and the like suitable for cultivation of the microorganism strain, and may also contain at least one supplementary carbon source. The amount of each of these additional ingredients to be employed is preferably selected to maximize 2-KGL production. Such amounts may be determined empirically by one skilled in the art according to the various methods and techniques known in the art. In a particularly preferred embodiment of the present invention, the culture medium contains about 10% (w/v) of L-sorbose, about 3% (wt. dry solids/v) of corn steep liquor, and about 0.2% (w/v) of MgSO.sub.4.7H.sub.2 O, with pH controlled using NH.sub.4 OH, Ca(OH.sub.2) or CaCO.sub.3. Medium for use in preparing inoculum may contain additional components as appropriate, such as peptone or N-Z Amine, supplemental carbon sources and/or various vitamins. Illustrative examples of suitable supplemental carbon sources include, but are not limited to: other carbohydrates, such as glucose, fructose, mannitol, starch or starch hydrolysate, cellulose hydrolysate and molasses; organic acids, such as acetic acid, propionic acid, lactic acid, formic acid, malic acid, citric acid, and fumaric acid; and alcohols, such as glycerol. Illustrative examples of suitable nitrogen sources include, but are not limited to: ammonia, including ammonia gas and aqueous ammonia; ammonium salts of inorganic or organic acids, such as ammonium chloride, ammonium nitrate, ammonium phosphate, ammonium sulfate and ammonium acetate; urea; nitrate or nitrite salts, and other nitrogen-containing materials, including amino acids as either pure or crude preparations, meat extract, peptone, fish meal, fish hydrolysate, corn steep liquor, casein hydrolysate, soybean cake hydrolysate, yeast extract, dried yeast, ethanol-yeast distillate, soybean flour, cottonseed meal, and the like. Illustrative examples of suitable inorganic salts include, but are not limited to: salts of potassium, calcium, sodium, magnesium, manganese, iron, cobalt, zinc, copper and other trace elements, and phosphoric acid. Illustrative examples of appropriate trace nutrients, growth factors, and the like include, but are not limited to: coenzyme A, pantothenic acid, biotin, thiamine, riboflavin, flavine mononucleotide, flavine adenine dinucleotide, other vitamins, amino acids such as cysteine, sodium thiosulfate, p-aminobenzoic acid, niacinamide, and the like, either as pure or partially purified chemical compounds or as present in natural materials. Cultivation of the inventive microorganism strain may be accomplished using any of the submerged fermentation techniques known to those skilled in the art, such as airlift, traditional sparged-agitated designs, or in shaking culture. The culture conditions employed, including temperature, pH, aeration rate, agitation rate, culture duration, and the like, may be determined empirically by one of skill in the art to maximize 2-KGL production. The selection of specific culture conditions depends upon factors such as the particular inventive microorganism strain employed, medium composition and type, culture technique, and similar considerations. In a particularly preferred embodiment of the present invention when employing strain NRRL B-21627 (ADM X6L) or a mutant or variant thereof, such as NRRL B-21630 (ADM 86-96), cultivation takes place at a temperature in the range of 22.degree. C. to 35.degree. C., preferably about 30.degree. C., and at a pH in the range of 5.0 to 8.0, preferably in the range of 5.5 to 7.5, more preferably about 6.0 to 6.8. The culture conditions employed can, of course, be varied by known methods at different timepoints during cultivation, as appropriate, to maximize 2-KGL production. After cultivation for a sufficient period of time, such as, for example, from 10 to 150 hours, the 2-KGL that has accumulated in the cells and/or culture broth is isolated according to any of the known methods. Any method that is suitable with the conditions employed for cultivation may be used; illustrative examples of suitable methods for recovering 2-KGL are described in U.S. Pat. Nos. 5,474,924; 5,312,741; 4,960,695; 4,935,359; 4,877,735; 4,933,289; 4,892,823; 3,043,749; 3,912,592; 3,907,639 and 3,234,105. According to one such method, the microorganisms are first removed from the culture broth by known methods, such as centrifugation or filtration, and the resulting solution concentrated in vacuo. Crystalline 2-KGL is then recovered by filtration and, if desired, purified by recrystallization. Similarly, 2-KGL can be recovered using such known methods as the use of ion-exchange resins, solvent extraction, precipitation, salting out and the like. When 2-KGL is recovered as a free acid, it can be converted to a salt, as desired, with sodium, potassium, calcium, ammonium or similar cations using conventional methods. Alternatively, when 2-KGL is recovered as a salt, it can be converted to its free form or to a different salt using conventional methods. In an alternative embodiment of the present invention, the inventive microorganism is cultivated in mixed culture with one or more helper strains. As used herein, "helper strain" is intended to mean a strain of a microorganism that increases the amount of 2-KGL produced in the inventive process. Suitable helper strains can be determined empirically by one skilled in the art. Illustrative examples of suitable helper strains include, but are not limited to, members of the following genera: Aureobacterium (preferably A. liquefaciens or A. saperdae), Coiynebacterium (preferably C. ammoniagenes or C. glutamicum), Bacillus, Brevibacterium (preferably B. linens or B. flavum), Pseudomonas, Proteus, Enterobacter, Citrobacter, Erwinia, Xanthomonas and Flavobacterium. Preferably, the helper strain is Corynebacterium glutamicum ATCC 21544. The helper strain is preferably incubated in an appropriate medium under suitable conditions for a sufficient amount of time until a culture of sufficient population is obtained. This helper strain inoculum may then be introduced into the culture medium for production of 2-KGL either separately or in combination with the inventive microorganism strain, i.e., a mixed inoculum. Preferably, the ratio of the amount of the helper strain relative to the amount of strain NRRL B-21627 (ADM X6L) is in the range of from 10:1 to 1:10,000. Another embodiment of the present invention is directed to the novel microorganism strains described above which are useful in fermentation processes for the production of 2-KGL. The following examples are illustrative only and are not intended to limit the scope of the invention as defined by the appended claims. It will be apparent to those skilled in the art that various modifications and variations can be made in the methods of the present invention without departing from the spirit and scope of the invention. Thus, it is intended that the present invention cover the modifications and variations of this invention provided they come within the scope of the appended claims and their equivalents. |
| PATENT EXAMPLES | This data is not available for free |
| PATENT PHOTOCOPY | Available on request |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |